Oral iron supplement and inflammatory bowel disease with iron deficiency anemia
10.3760/cma.j.cn101480-20210206-00009
- VernacularTitle:口服铁剂与炎症性肠病合并缺铁性贫血
- Author:
Miaomiao LU
1
;
Yue REN
;
Lingling XU
;
Xuewei GU
;
Ziyan LYU
;
Dong CHEN
;
Xi JIN
Author Information
1. 浙江大学医学院,杭州 310000
- Publication Type:Journal Article
- Keywords:
Inflammatory bowel disease;
Anemia, iron deficiency;
Iron supplement, oral;
Iron absorption
- From:
Chinese Journal of Inflammatory Bowel Diseases
2022;06(2):150-154
- CountryChina
- Language:Chinese
-
Abstract:
Iron deficiency anemia (IDA) is one of the common complications of inflammatory bowel disease (IBD) . Oral iron supplement is a commonly used treatment for IDA, and its role in IBD patients with IDA has always been controversial. There are problems such as oral iron intolerance and poor absorption in IBD patients. Studies showed that oral iron would increase the disease activity index in IBD patients, which may be related to oxidative stress induced by intestinal iron and change the composition of intestinal flora. This article summarizes the diagnostic criteria and treatment of IBD with IDA, explores the advantages and disadvantages of oral iron supplement and the treatment controversy, and puts forward iron supplement strategy.